Cover Image
Market Research Report
Product code
1007241

Asia Pacific Anticoagulant Reversal Drug Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product ; End User

Published: | The Insight Partners | 149 Pages | Delivery time: 1-2 business days

Price

Back to Top
Asia Pacific Anticoagulant Reversal Drug Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product ; End User
Published: May 6, 2021
The Insight Partners
Content info: 149 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

The anticoagulant reversal drug market in Asia Pacific is expected to grow from US$ 173.5 million in 2019 to US$ 444.8 million by 2027; it is estimated to grow at a CAGR of 13.2% from 2019 to 2027. Anticoagulant reversal drugs are used in the management of hemorrhagic stroke to decrease bleeding and allow tissues to recover. There has been increase in stroke prevalence in low- and middle-income countries. As per the study "Incidence & prevalence of stroke in India: A Systematic Review," published in 2017, the cumulative frequency of stroke in India ranged from 105 to 152 per 100,000 persons per year. These values are higher than those in high-income countries. Such high prevalence of stroke contributes to the high demand for anticoagulant reversal drugs in Asia Pacific countries.

Based on product, the Asia Pacific anticoagulant reversal drugs market is segmented into prothrombin complex concentrates, vitamin K, AndeXXa, protamine, idarucizumab, and tranexamic acid. In 2019, the vitamin K segment accounted for the largest market share. It is a reliable and fast alternative to fresh frozen plasma to control excessive bleeding as it has properties to reverse the effects of oral anticoagulant treatments, which contributes to the wide acceptance for this product. On the other hand, the market for AndeXXa is expected to grow at the fastest CAGR during the forecast period.

The Covid-19 outbreak in late January 2020 has led to an overwhelming demand for anticoagulant reversal drugs due to the rising demand for hospital beds. China and India are among the key contributors to the global drug discovery and manufacturing. Healthcare professionals are innovating and developing procedures to treat heart failure in COVID-19 infected patients. For instance, in October 2020, the experts in the University of Sydney discovered a method to treat highly contagious COVID-19 patients with ailing hearts within intensive care units. This is expected to be the pioneer study that has been fast-tracked for COVID-19 patients with cardiovascular complexities. Further, it is assumed to be useful for treating acute heart failure, in general. Thus, the anticoagulant reversal drug market in the Asia Pacific has witnessed minimal impact of the pandemic.

The Asia Pacific anticoagulant reversal drug market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. The process also serves the purpose of obtaining overview and forecast for the Asia Pacific anticoagulant reversal drug market with respect to all the segments pertaining to the region. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data, as well as to gain more analytical insights into the topic. The participants of this process include industry expert such as VPs, business development managers, market intelligence managers, and national sales managers-along with external consultants such as valuation experts, research analysts, and key opinion leaders-specializing in the Asia Pacific anticoagulant reversal drug market. Boehringer Ingelheim International GmbH, Pfizer Inc, Octapharma AG, Fresenius Kabi AG, Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals), CSL Limited, and Grifols, S.A., China Biologic Products, Inc., and Shanghai RAAS Blood Products Co., Ltd. are among the players operating in the market in this region.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific anticoagulant reversal drug market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific anticoagulant reversal drug market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the anticoagulant reversal drug market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution 
Table of Contents
Product Code: TIPRE00022193

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Anticoagulant Reversal Drug Market - By Product
    • 1.3.2 Anticoagulant Reversal Drug Market - By Distribution Channel
    • 1.3.3 Asia Pacific Anticoagulant Reversal Drug Market - By Country

2. Asia Pacific Anticoagulant Reversal Drug Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Anticoagulant Reversal Drug Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Anticoagulant Reversal Drug Market- Asia Pacific PEST Analysis
  • 4.3 Expert Opinion

5. Asia Pacific Anticoagulant Reversal Drug Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rise in Prevalence of Atrial Fibrillation (AFib)
    • 5.1.2 Increase in Prevalence of Stroke
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Anticoagulant Reversal Drugs
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Research Activities on Anticoagulant Reversal Drugs
  • 5.4 Future Trends
    • 5.4.1 Development and Launch of Innovative Products
  • 5.5 Impact Analysis

6. Anticoagulant Reversal Drug Market - Asia Pacific Analysis

  • 6.1 Asia Pacific Anticoagulant Reversal Drug Market Revenue Forecasts and Analysis

7. Asia Pacific Anticoagulant Reversal Drug Market Analysis and Forecasts To 2027 - By Product

  • 7.1 Overview
  • 7.2 Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)
  • 7.3 Prothrombin Complex Concentrates
    • 7.3.1 Overview
    • 7.3.2 Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • 7.4 Vitamin K
    • 7.4.1 Overview
    • 7.4.2 Vitamin K: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • 7.5 Protamine
    • 7.5.1 Overview
    • 7.5.2 Protamine: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • 7.6 Tranexamic Acid
    • 7.6.1 Overview
    • 7.6.2 Tranexamic Acid: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • 7.7 Idarucizumab
    • 7.7.1 Overview
    • 7.7.2 Idarucizumab: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • 7.8 Andexxa

8. Asia Pacific Anticoagulant Reversal Drug Market Analysis and Forecasts to 2027- By Distribution Channel

  • 8.1 Overview
  • 8.2 Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)
  • 8.3 Hospital Pharmacies
    • 8.3.1 Overview
    • 8.3.2 Hospital Pharmacies: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • 8.4 Retail Pharmacies
    • 8.4.1 Overview
    • 8.4.2 Retail Pharmacies: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)

9. Anticoagulant Reversal Drug Market Revenue and Forecasts to 2027 - Geographical Analysis

  • 9.1 Asia Pacific: Anticoagulant Reversal Drugs Market
    • 9.1.1 Overview
    • 9.1.2 Asia Pacific: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
    • 9.1.3 China: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.3.1 China: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.3.2 China: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.1.3.3 China: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.1.4 Japan: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.4.1 Japan: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.4.2 Japan: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.1.4.3 Japan: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.1.5 India: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.5.1 India: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.5.2 India: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.1.5.3 India: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.1.6 South Korea: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.6.1 South Korea: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.6.2 South Korea: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.1.6.3 South Korea: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.1.7 Australia: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.7.1 Australia: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.7.2 Australia: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.1.7.3 Australia: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
    • 9.1.8 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.8.1 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.8.2 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
      • 9.1.8.3 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)

10. Impact Of COVID-19 Pandemic on Asia Pacific Anticoagulant Reversal Drug Market

  • 10.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
    • 11.2.2 Organic Developments Done By Companies
  • 11.3 Inorganic Developments
    • 11.3.1 Overview
    • 11.3.2 Inorganic Developments Done By Companies

Source: The Insight Partners Analysis, Website, Press Releases and Others

12. COMPANY PROFILES

  • 12.1 Boehringer Ingelheim International GmbH
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Pfizer Inc.
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Octapharma AG
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Fresenius Kabi AG
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 CSL Limited
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 China Biologic Products, Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Grifols, S.A.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Shanghai RAAS Blood Products Co., Ltd.
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. China: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 2. China: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 3. Japan: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 4. Japan: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 5. India: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 6. India: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 7. South Korea: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 8. South Korea: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Australia: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Australia: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Product - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Glossary of Terms, Anticoagulant Reversal Drug Market

List Of Figures

  • Figure 1. Anticoagulant Reversal Drug Market Segmentation
  • Figure 2. Asia Pacific Anticoagulant Reversal Drug Market Overview
  • Figure 3. Prothrombin Complex Concentrates Segment Held Largest Share of Product in Anticoagulant Reversal Drug Market
  • Figure 4. Hospital Pharmacies Segment Held Largest Share of Distribution Channel in Anticoagulant Reversal Drug Market
  • Figure 5. India is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Anticoagulant Reversal Drug Market - Asia Pacific PEST Analysis
  • Figure 7. Anticoagulant Reversal Drug Market Impact Analysis of Driver and Restraints
  • Figure 8. Asia Pacific Anticoagulant Reversal Drug Market - Revenue Forecasts and Analysis - 2019- 2027
  • Figure 1. Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)
  • Figure 2. Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 3. Vitamin K: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 4. Protamine: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 5. Tranexamic Acid: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 6. Idarucizumab: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 7. Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)
  • Figure 8. Hospital Pharmacies: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 9. Retail Pharmacies: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 10. Others: Anticoagulant Reversal Drugs Market- Revenue and Forecast to 2027 (USD Million)
  • Figure 11. Asia Pacific: Anticoagulant Reversal Drugs Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 12. Asia Pacific: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
  • Figure 13. China: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 14. Japan: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 15. India: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 16. South Korea: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 17. Australia: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 18. Rest of Asia Pacific: Anticoagulant Reversal Drugs Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 19. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 20. Growth Strategies Done by the Companies in the Market, (%)